Author

D. R. Bielenberg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Sim· 2 shared L. A. Akslen· 2 shared L. Sui· 2 shared R. S. Watnick· 2 shared S. Aziz· 2 shared S. Wang· 2 shared A. Borretzen· 1 shared A. E. Birsner· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Sim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting endothelial FOXO1 protects diabetic β-cells and improves wound healing

H. Wu, K. Cui, B. Zhu, Y. W. Lu, L. Sun, Q. Ma, A. Jian, D. O. Hurtado, X. Gao, Y. Li, S. Bhattacharjee, H. Fu, A. E. Birsner, M. Malovichko, M. Li, , H. Chen

This study shows that targeting endothelial FOXO1 reduces IGF2 levels, improves β-cell function, and enhances wound healing in diabetes.

bioRxiv · Dec 4, 2023 · PreprintCell Biology

PRSS2 stimulates tumor growth by remodeling the TME via repression of Tsp1

L. Sui, S. Wang, D. Ganguly, T. El Rayes, C. Askeland, A. Borretzen, K. Zhou, D. Sim, O. J. Halvorsen, G. Knutsvik, S. Aziz, S. Haukaas, W. D. Foulkes, D. R. Bielenberg, A. Ziemys, , R. S. Watnick

This study identifies PRSS2 as a factor that represses Tsp-1 in the tumor microenvironment by binding to LRP1, promoting tumor growth.

bioRxiv · Mar 23, 2021 · PreprintCancer Biology

Notch1 regulates breast cancer stem cell function via a non-canonical cleavage-independent pathway

L. Sui, S. Wang, R. K. Rodriguez, D. Sim, N. Bhattacharya, A. L. Blois, T. Schlaeger, S. Chen, S. Aziz, M. S. Rogers, D. R. Bielenberg, L. A. Akslen, R. S. Watnick

This study identifies a non-canonical Notch1 pathway that represses SIRT1 to drive tumor initiation and chemoresistance in breast cancer stem cells.

bioRxiv · Feb 28, 2020 · PreprintCancer Biology